As the Business Development Manager at Immunologix Laboratories, Alex Piante plays a pivotal role in driving strategic growth and fostering partnerships that enhance the laboratory's reputation as a leader in bioanalytical services. Reporting directly to Dr. Corinna Fiorotti, the Chief Commercial Officer, Alex leverages his...
As the Business Development Manager at Immunologix Laboratories, Alex Piante plays a pivotal role in driving strategic growth and fostering partnerships that enhance the laboratory's reputation as a leader in bioanalytical services. Reporting directly to Dr. Corinna Fiorotti, the Chief Commercial Officer, Alex leverages his extensive expertise in business development and data analysis to identify new market opportunities and cultivate relationships with pharmaceutical and biotechnology companies. His deep understanding of ligand binding-based bioanalysis, immunogenicity, and pharmacokinetics positions him as a key resource for clients navigating the complexities of preclinical and clinical development.
Alex is currently spearheading several key projects aimed at expanding Immunologix's service offerings in neutralizing antibody assays and biomarker analysis. By collaborating closely with the Translational Sciences team, he ensures that clients receive not only high-quality GLP and GCP compliant laboratory services but also expert scientific consultation tailored to their specific needs. His proficiency in utilizing tools such as PowerPoint and Microsoft Office allows him to effectively communicate complex data and insights to stakeholders, facilitating informed decision-making.
With a strong foundation in molecular biology and hands-on experience with HPLC techniques, Alex is adept at translating scientific concepts into actionable business strategies. His commitment to excellence and continuous learning in the rapidly evolving field of bioanalysis makes him an invaluable asset to Immunologix Laboratories, as he works to enhance the company’s competitive edge and drive innovation in the life sciences sector.